Drupal.behaviors.print = function(context) {window.print();window.close();}>
Asuragen Nets $3.8M in SBIR/STTR Grants
October 07, 2009
Asuragen Nets $3.8M in SBIR/STTR Grants
By a GenomeWeb staff reporter
The firm will use the NIH grants to develop biomarkers, diagnostics, and microarray technologies.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Startup Twistnostics Developing Rapid Microarray Platform for PGx and Infectious Disease Assays
March 26, 2013 / BioArray News
Pathwork's Economics Study Finds TOO Test 'Strongly' Cost-Effective in Extending Survival
January 18, 2012 / Pharmacogenomics Reporter
Nanosphere Releases Data on Gram-Positive Blood Culture Test Ahead of Anticipated FDA Approval
October 4, 2011 / BioArray News
In Brief This Week: Life Technologies, Asuragen; Synthetic Genomics, Exxon Mobil; Immucor; Tecan; Millipore
July 16, 2010 / GenomeWeb Daily News
Asuragen Inks Distribution Deal for France
March 22, 2010 / GenomeWeb Daily News